Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

John Carroll to Septal Occluder Device

This is a "connection" page, showing publications John Carroll has written about Septal Occluder Device.

 
Connection Strength
 
 
 
4.635
 
  1. Won H, Carroll JD. Comparative effectiveness research applied to medical devices: Which PFO closure device is the best? Catheter Cardiovasc Interv. 2020 02 15; 95(3):373-374.
    View in: PubMed
    Score: 0.791
  2. Carroll AM, Carroll JD. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials. Curr Cardiol Rep. 2019 04 22; 21(6):48.
    View in: PubMed
    Score: 0.747
  3. Carroll JD. A Positive Bubble Test Post-Patent Foramen Ovale Closure: Was Satisfaction-of-Search to Blame? JACC Cardiovasc Interv. 2018 06 11; 11(11):1105-1107.
    View in: PubMed
    Score: 0.704
  4. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013 Mar 21; 368(12):1092-100.
    View in: PubMed
    Score: 0.490
  5. Crawford GB, Brindis RG, Krucoff MW, Mansalis BP, Carroll JD. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):157-67.
    View in: PubMed
    Score: 0.461
  6. Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, Gold MR, Hermiller J, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, O'Brien L, Windecker S. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial. Circulation. 2021 11 09; 144(19):1543-1552.
    View in: PubMed
    Score: 0.220
  7. Lakkireddy D, Windecker S, Thaler D, Søndergaard L, Carroll J, Gold MR, Guo H, Brunner KJ, Hermiller JB, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, Levine J. Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). Am Heart J. 2019 05; 211:45-53.
    View in: PubMed
    Score: 0.182
  8. Zipse MM, Messenger JC, Carroll JD, Seres T. Percutaneous repair of right ventricular perforation with Amplatzer septal defect occlusion device. Eur Heart J. 2018 03 01; 39(9):817.
    View in: PubMed
    Score: 0.173
  9. Wiktor DM, Carroll JD. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke. Circ Cardiovasc Interv. 2018 03; 11(3):e004152.
    View in: PubMed
    Score: 0.173
  10. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke. N Engl J Med. 2017 09 14; 377(11):1022-1032.
    View in: PubMed
    Score: 0.167
  11. Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE. Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials. J Am Coll Cardiol. 2016 Mar 01; 67(8):907-917.
    View in: PubMed
    Score: 0.150
  12. Clegg SD, Chen SJ, Nijhof N, Kim MS, Salcedo EE, Quaife RA, Messenger JC, Bracken J, Carroll JD. Integrated 3D echo-x ray to optimize image guidance for structural heart intervention. JACC Cardiovasc Imaging. 2015 Mar; 8(3):371-374.
    View in: PubMed
    Score: 0.140
  13. Carroll JD. Double standards in the world of ASD and PFO management: closure for paradoxical embolism. Catheter Cardiovasc Interv. 2009 Dec 01; 74(7):1070-1.
    View in: PubMed
    Score: 0.097
  14. Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, Jüni P, Kim JS, Koethe B, Lee PH, Lefebvre B, Mattle HP, Meier B, Reisman M, Smalling RW, Soendergaard L, Song JK, Mas JL, Thaler DE. Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke. JAMA. 2021 12 14; 326(22):2277-2286.
    View in: PubMed
    Score: 0.056
  15. Messé SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020 05 19; 94(20):876-885.
    View in: PubMed
    Score: 0.050
  16. Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015 Jan 07; 36(2):120-8.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)